We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$204M
AUM Growth
+$15.9M
Cap. Flow
+$17.5M
Cap. Flow %
8.58%
Top 10 Hldgs %
6.14%
Holding
488
New
66
Increased
245
Reduced
135
Closed
40

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$976K
2
NFLX icon
Netflix
NFLX
+$953K
3
CRWD icon
CrowdStrike
CRWD
+$952K
4
RCL icon
Royal Caribbean
RCL
+$905K
5
TJX icon
TJX Companies
TJX
+$890K

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.11M
2
LLY icon
Eli Lilly
LLY
+$937K
3
FCX icon
Freeport-McMoran
FCX
+$933K
4
ALGN icon
Align Technology
ALGN
+$933K
5
MLM icon
Martin Marietta Materials
MLM
+$930K

Sector Composition

Rank Sector Weight
1 Financials 26.66%
2 Healthcare 19.14%
3 Technology 17.16%
4 Energy 7.21%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
401
Regenxbio
RGNX
$622M
$81K 0.04%
6,921
+2,762
+66% +$43K
LQDA icon
402
Liquidia Corp
LQDA
$7.51B
$80.9K 0.04%
6,741
-5,144
-43% -$68.3K
ABCL icon
403
AbCellera Biologics
ABCL
$1.6B
$80.5K 0.04%
27,185
+11,373
+72% +$43K
XNCR icon
404
Xencor
XNCR
$1.47B
$80.4K 0.04%
4,248
+161
+4% +$3.46K
APLT
405
DELISTED
Applied Therapeutics
APLT
$80.4K 0.04%
+17,210
New +$81.4K
SRRK icon
406
Scholar Rock
SRRK
$5.86B
$80K 0.04%
9,600
+4,929
+106% +$60.3K
VERV
407
DELISTED
Verve Therapeutics
VERV
$78.9K 0.04%
16,165
+10,119
+167% +$63.6K
CMPS
408
Compass Pathways
CMPS
$1.52B
$78.8K 0.04%
13,044
+1,823
+16% +$14.3K
OLMA icon
409
Olema Pharmaceuticals
OLMA
$1.05B
$78.6K 0.04%
7,265
+235
+3% +$2.55K
NGNE icon
410
Neurogene
NGNE
$691M
$78.5K 0.04%
+2,156
New +$76K
IGMS
411
DELISTED
IGM Biosciences
IGMS
$78.3K 0.04%
11,401
-1,931
-14% -$16.5K
ETNB
412
DELISTED
89bio
ETNB
$78K 0.04%
9,744
+1,706
+21% +$15.2K
NTLA icon
413
Intellia Therapeutics
NTLA
$1.49B
$78K 0.04%
3,487
+768
+28% +$18.3K
FDMT icon
414
4D Molecular Therapeutics
FDMT
$543M
$77.9K 0.04%
3,709
-1,506
-29% -$37.8K
CATX icon
415
Perspective Therapeutics
CATX
$322M
$77.8K 0.04%
+7,803
New +$113K
VIR icon
416
Vir Biotechnology
VIR
$1.48B
$77.8K 0.04%
8,738
+108
+1% +$1.04K
KYMR icon
417
Kymera Therapeutics
KYMR
$9.05B
$77.5K 0.04%
2,596
-811
-24% -$28.1K
TERN
418
DELISTED
Terns Pharmaceuticals
TERN
$77.3K 0.04%
11,344
-2,028
-15% -$12.3K
QURE icon
419
uniQure
QURE
$2.63B
$77.2K 0.04%
17,243
+6,550
+61% +$31.9K
EDIT icon
420
Editas Medicine
EDIT
$411M
$77K 0.04%
16,489
+8,499
+106% +$47.9K
CVAC
421
DELISTED
CureVac
CVAC
$76.9K 0.04%
22,631
+7,643
+51% +$25K
RLAY icon
422
Relay Therapeutics
RLAY
$4.06B
$75.4K 0.04%
11,569
+2,867
+33% +$19.6K
BCYC
423
Bicycle Therapeutics
BCYC
$276M
$75.4K 0.04%
3,725
-2,049
-35% -$46.3K
ANNX icon
424
Annexon
ANNX
$841M
$73.8K 0.04%
+15,063
New +$77.9K
TYRA icon
425
Tyra Biosciences
TYRA
$1.85B
$72.9K 0.04%
+4,560
New +$78.5K
15 16
17
18 19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Virtus ETF Advisers held 488 positions worth $204M, up 8.5% from $188M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $17.5M of net new capital in Q2 2024, opening 66 new positions and adding to 245 existing holdings. Its largest new stake was Qualcomm: 5,165 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Extra Space Storage, an estimated $732K trimmed.

  • Virtus ETF Advisers's largest Q2 2024 buy was Qualcomm: 5,165 shares worth $1.03M.
  • Virtus ETF Advisers added most to EOG Resources in Q2 2024, an estimated $789K increase.
  • Virtus ETF Advisers's biggest Q2 2024 reduction was Extra Space Storage, cutting an estimated $732K.
  • Virtus ETF Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.11M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $204M portfolio in Q2 2024.
  • Virtus ETF Advisers opened 66 new positions and closed 40 in Q2 2024.
  • Virtus ETF Advisers's portfolio value rose 8.5% quarter-over-quarter to $204M.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.